Raymond James Financial
INSM icon

Raymond James Financial’s Insmed INSM Stock Holding History

Raymond James Financial’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$121M Sell
775,148
-4,106
-0.5% -$631K 0.04% 441
2025
Q4 		$136M Buy
779,254
+19,276
+3% +$3.52M 0.04% 389
2025
Q3 		$109M Sell
759,978
-24,573
-3% -$3.01M 0.04% 469
2025
Q2 		$79M Buy
784,551
+375,614
+92% +$28.7M 0.03% 561
2025
Q1 		$31.2M Buy
408,937
+45,491
+13% +$3.48M 0.01% 1001
2024
Q4 		$25.1M Buy
+363,446
New +$26.2M 0.01% 1148

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Raymond James Financial's INSM Position: Q1 2026 in Review

Raymond James Financial reduced its Insmed (INSM) stake by 0.53% in Q1 2026, selling an estimated $631K and leaving 775,148 shares worth $121M. The position accounts for 0.04% of the portfolio, ranked #441.

Raymond James Financial first reported a position in INSM in Q4 2024 and has held it in 6 quarters since. The position peaked at $136M in Q4 2025. 672 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Raymond James Financial held 775,148 shares of Insmed worth $121M as of Q1 2026.
  • Raymond James Financial sold 4,106 Insmed shares in Q1 2026, an estimated $631K.
  • Insmed made up 0.04% of Raymond James Financial's portfolio in Q1 2026, its #441 holding.
  • Raymond James Financial first reported a position in Insmed in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Insmed position peaked at $136M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.